QUARTA, SANTINA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 4.008
AS - Asia 970
EU - Europa 829
SA - Sud America 90
AF - Africa 14
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.914
Nazione #
US - Stati Uniti d'America 4.002
SG - Singapore 437
CN - Cina 419
IT - Italia 226
FI - Finlandia 136
SE - Svezia 124
DE - Germania 118
BR - Brasile 85
HK - Hong Kong 45
PL - Polonia 45
RU - Federazione Russa 39
FR - Francia 34
IN - India 30
GB - Regno Unito 28
UA - Ucraina 27
VN - Vietnam 19
NL - Olanda 17
IE - Irlanda 16
AT - Austria 9
CI - Costa d'Avorio 9
BD - Bangladesh 3
BE - Belgio 3
BG - Bulgaria 3
JO - Giordania 3
MA - Marocco 3
MX - Messico 3
PK - Pakistan 3
AU - Australia 2
AZ - Azerbaigian 2
CA - Canada 2
AE - Emirati Arabi Uniti 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
EC - Ecuador 1
EU - Europa 1
IQ - Iraq 1
JM - Giamaica 1
JP - Giappone 1
KE - Kenya 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MN - Mongolia 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 5.914
Città #
Fairfield 502
Chandler 418
Woodbridge 283
Singapore 263
Houston 239
Jacksonville 231
Wilmington 229
Ann Arbor 220
Ashburn 215
Cambridge 195
Seattle 186
Santa Clara 149
Boardman 131
Padova 104
Princeton 79
Helsinki 74
Des Moines 72
San Diego 66
Nanjing 64
Medford 57
Beijing 55
Bytom 45
Hong Kong 44
Dearborn 40
Roxbury 35
New York 28
Shenyang 24
Guangzhou 23
Changsha 21
Hefei 20
Pune 17
Dublin 16
Dong Ket 15
Jinan 15
Jiaxing 14
Nanchang 14
Kunming 13
Hebei 12
London 11
Nuremberg 11
Tianjin 11
Abidjan 9
Detroit 9
Shanghai 9
Frankfurt am Main 7
Paris 7
Turku 7
Dallas 6
Falkenstein 6
Florence 6
Milan 6
Norwalk 6
Redwood City 6
Rome 6
Munich 5
Ningbo 5
Springfield 5
Villafranca Padovana 5
Zhengzhou 5
Haikou 4
Los Angeles 4
Ogden 4
Pesaro 4
Phoenix 4
Rockville 4
Turin 4
Viareggio 4
Wuhan 4
Amman 3
Düsseldorf 3
Embu das Artes 3
Joinville 3
Prineville 3
Sofia 3
São Paulo 3
Urbino 3
Venezia 3
Vienna 3
Washington 3
Afragola 2
Amsterdam 2
Atlanta 2
Baku 2
Brescia 2
Campodarsego 2
Columbus 2
Fossò 2
Fuzhou 2
Gubbio 2
Hangzhou 2
Hanoi 2
Hanover 2
Ho Chi Minh City 2
Kharkiv 2
Legnaro 2
Manaus 2
Newark 2
Osasco 2
Porto Alegre 2
Portsmouth 2
Totale 4.487
Nome #
Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles 196
PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting 183
Synthesis, chemical characterization and cancer cell growth-inhibitory activities of Cu(ii) and Ru(iii) aliphatic and aromatic dithiocarbamato complexes 168
SCCA1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity 166
Biological and clinical implications of HBV infection in peripheral blood mononuclear cells 149
SERPINB3 induces epithelial-mesenchymal transition. 131
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma 128
Re-programming pullulan for targeting and controlled release of doxorubicin to the hepatocellular carcinoma cells 127
SERPINB3, apoptosis and autoimmunity 125
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 124
Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice. 117
Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma 114
SERPINB3 INDUCES EPITHELIAL MESENCHYMAL TRANSITION 112
Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour? 111
Au(III)-Proline derivatives exhibiting selective antiproliferative activity against HepG2/SB3 apoptosis-resistant cancer cells 110
Hepatic progenitor cells express SerpinB3 107
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease 106
Exogenous Administration of SERPINB3 Inhibits Cell Reprogramming 106
SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma 105
Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett's carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy 100
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 99
Low p66shc with high serpinb3 levels favors necroptosis and better survival in hepatocellular carcinoma 99
Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis 87
Activation of pivotal cell cycle proteins and inhibition of apoptosis by SCCA1 in HepG2 cells 86
SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells 85
Monitoring SCCA-IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis 82
HEPATIC PROGENITOR CELLS OVEREXPRESS SERPINB3 IN A MOUSE MODEL OF FULMINANT HEPATITIS 82
SERPINB3 INDUCES EPITHELIAL MESENCHYMAL TRANSITION 79
Circulating Squamous Cell Carcinoma Antigen-IgM complexes as novel biomarkers for hepatocellular carcinoma 76
SCCA overexpression induces cell proliferation and down-regulation of the adhesion system 76
Biodistribution of Intratracheal, Intranasal, and Intravenous Injections of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles in a Mouse Model for Drug Delivery Studies 75
RUOLO DI SERPINB3 ELLA PROGRESSIONE DELLA MALATTIA EPATICA 71
ESPRESSIONE DELLA SERPINA SCCA IN CELLULE MONONUCLEATE DI SANGUE PERIFERICO IN PAZIENTI CO INFEZIONE CRONICA DA HCV 71
Labelled micelles for the delivery of cytotoxic Cu(II) and Ru(III) compounds in the treatment of aggressive orphan cancers: design and biological in vitro data 71
Espressione della serpina SCCA in cellule mononucleate di sangue periferico in pazienti con infezione cronica da HCV 70
Deregulation of Squamous Cell Carcinoma Antigen (SCCA) expression in B lymphocytes in patients with chronic hepatitis C 70
HYPOXIA UP-REGULATES SERPINB3 IN HEPG2 CELLS: A REDOX SENSITIVE EVENT RELATED TOEPITHELIAL TO MESENCHYMAL TRANSITIONAND INVASIVENESS 69
HPYPOXYA UP-REGULATES SERPINB3 IN HEPATIC CANCER CELLS: A HIF-2a ASSOCIATED EVENT RELATED TO INVASIVENESS AND EPITHELIAL TO MESENCHYMAL TRANSITION 69
DEREGOLAZIONE DELL’ESPRESSIONE DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) NEI LINFOCITI B IN PAZIENTI INFETTI DA HCV 69
SQUAMOUS CELL CARCINOMA ANTIGEN (SCCA) ENHANCES LIVER REGENERATION AFTER PARTIAL HEPATECTOMY 68
CARATTERIZZAZIONE BIOLOGICA E FUNZIONE DELLA NUOVA ISOFORMA SCCA-PD 67
SCCA EXPRESSION IN PBMCs IN PATIENTS WITH CHRONIC HEPATITIS C 66
Vescicole extracellulari da cellule geneticamente modificate iperesprimenti SerpinB3 per uso come agenti terapeutici 66
SERPINB3 modulates TGF-beta expression in chronic liver disease. 65
SCCA1-IGM AND SCCA2-IGM COMPARED WITH TOTAL SCCA-IGM FOR DIAGNOSIS OF HEPATOCELLULAR CARCINOMA 65
HCC invasiveness induced by SCCA is associated with nuclear beta-catenin accumulation 65
Monitoring SCCA-IgM complex predicts liver disease progression in patients with chronic hepatitis and cirrhosis 63
HFE, TGF-BETA1 AND SQUAMOUS CELL CARCNOMA ANTIGEN-1 POLYMORPHISMS AND LIVER DISEASE STAGE IN CHRONIC HCV INFECTION 62
CHARACTERIZATION OF SCCA-1(SERPINB3) ISOFORMS IN HEPATOCELLULAR CARCINOMA 62
1-Piperidine Propionic Acid as an Allosteric Inhibitor of Protease Activated Receptor-2 61
OVEREXPRESSION OF SERPINB3 IN HEPATIC PROGENITOR CELLS IN A MOUSE MODEL OF ACUTE LIVER INJURY 60
POLIMORFISMO DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) E PROGRESSIONE DELLA MALATTIA EPATICA NELL’INFEZIOE HCV 60
SERPINB3 PROMUOVE L’INVASIVITA’ CELLULARE 59
Serum SCCA IgM complexes increase over time and HCC development in cirrhotic patients 58
DOWNREGULATION OF SURFACE SQUAMOUS CELL CARCINOMA ANTIGEN EXPRESSION AND CD27+ MOLECULE ON B LYMPHOCYTES IN PATIENTS WITH CHRONIC HEPATITIS C 57
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma 57
SEX DEPENDENT IL-6 DEREGULATION BY SERPINB3 IN A TRANSGENIC MOUSE MODEL 54
CELLULE PROGENITRICI EPATICHE ESPRIMONO SERPINB3 IN UN MODELLO MURINO DI EPATITE FULMINANTE 53
PRO-ONCOGENIC EFFECT OF SQUAMOUS CELL CARCINOMA ANTIGEN VIA WNT/BETA-CATENIN SIGNALING 52
Squamous cell carcinoma antigen (SCCA) expression and CD27+ memory B lymphocytes in patients with chronic hepatitis C and systemic lupus erythematosus (SLE) 52
ESPRESSIONE DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) E CELLULE B DELLA MEMORIA IN CORSO DI INFEZIONE DA VIRUS DELL’EPATITE C 52
COMPORTAMENTO DI SCCA-IgM NEL SIERO DI BAMBINI HBeAg POSITIVI SEGUITI NEL TEMPO 51
SERPINB3 AS A PRO-INFLAMMATORY MEDIATOR IN THE PROGRESSION OF EXPERIMENTAL NON-ALCOHOLIC FATTY LIVER DISEASE. 48
ESPRESSIONE DI TGF-b1 NELLA MALATTIA EPATICA EVOLUTIVA 48
SERPINB3 AND TGF-BETA IN CHRONIC LIVER DISEASE 43
Hepatotropic viruses: new insights in pathogenesis and treatment 41
SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE OF VIRAL ETIOLOGY 38
MODULAZIONE DEI LIVELLI DI IL-6 NELLA RIGENERAZIONE EPATICA DA PARTE DI SERPINB3 ED ESTROGENI. ANALISI IN UN MODELLO DI TOPO TRANSGENICO 37
SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE 35
SERPINB3 UP-REGULATION BY HYPOXIA IN HEPG2 CELLS : A HIF-2ALPHA AND REDOX SENSITIVE EVENT RELATED TO INVASIVENESS AND EPITHELIAL TO MESENCHYMAL TRANSITION 32
1-Piperidine Propionic Acid Protects from Septic Shock Through Protease Receptor 2 Inhibition 27
Semisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo 25
The Protease Activated Receptor 2 - CCAAT/Enhancer-Binding Protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of Non-Alcoholic Steatohepatitis 24
Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition 24
SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness 20
SerpinB3 administration protects liver against ischemia-reperfusion injury 18
Inhibition of Protease-Activated Receptor-2 Activation in Parkinson’s Disease Using 1-Piperidin Propionic Acid 18
The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation 18
A New Assay for Quantitative Determination of Pres1-Encoded Protein in Patients Infected with Hepatitis B and Delta Viruses 14
Totale 5.956
Categoria #
all - tutte 24.073
article - articoli 19.562
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 232
selected - selezionate 0
volume - volumi 0
Totale 43.867


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202097 0 0 0 0 0 0 0 0 0 0 52 45
2020/2021743 29 36 23 35 24 65 20 39 101 173 98 100
2021/2022711 19 103 79 58 27 47 32 64 33 9 81 159
2022/2023885 140 88 18 96 153 146 0 79 107 6 38 14
2023/2024457 14 65 67 29 49 67 39 17 10 18 35 47
2024/20251.286 10 202 75 99 212 67 89 130 152 99 151 0
Totale 5.956